BioCentury
ARTICLE | Clinical News

Emtricitabine once-daily nucleoside reverse transcriptase inhibitor regulatory update

January 13, 2003 8:00 AM UTC

VIRS said the EMEA accepted for filing its MAA for emtricitabine to treat HIV infection. The compound is under review in the U.S., where it has the tradename Coviracil. Gilead Sciences Inc. (GILD, F...